KPRX vs KRRO

Kiora Pharmaceuticals, Inc. vs Korro Bio, Inc. — Valuation Comparison 2026

KPRX

Pharmaceutical Preparations
Kiora Pharmaceuticals, Inc.
Quality
5.5
out of 10
Value Trap
33
LOW
Price
$2.68
Last close
Models
8/13
Active
VS

KRRO

Pharmaceutical Preparations
Korro Bio, Inc.
Quality
5.1
out of 10
Value Trap
28
LOW
Price
$13.41
Last close
Models
9/13
Active

Model-by-Model Comparison

ModelType KPRX Fair ValueKPRX Upside KRRO Fair ValueKRRO Upside
Bayesian DCF Intrinsic $2.01 -24.8% $3.85 -71.3%
First Chicago Scenario $•••.•• ••.•% $•••.•• ••.•%
ML-RIV Intrinsic $0.48 -80.2% $0.79 -94.2%
Dynamic NAV Asset-Based $4.83 +80.3% $9.46 -29.4%
PWERM Option-Based $•••.•• ••.•% $•••.•• ••.•%
Regime Cross-Sectional Relative $•••.•• ••.•% $•••.•• ••.•%
Sentiment SOTP Hybrid $•••.•• ••.•% $•••.•• ••.•%
CUCE Ensemble Ensemble $•••.•• ••.•% $•••.•• ••.•%
FTNN Topology Relative $•••.•• ••.•% $•••.•• ••.•%
🔒

Unlock Full 13-Model Comparison

Access all valuation models for KPRX vs KRRO — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

KPRX vs KRRO — Which Stock Is More Undervalued?

KPRX scores higher with a 5.5/10 quality rating vs KRRO's 5.1/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing Kiora Pharmaceuticals, Inc. (KPRX) and Korro Bio, Inc. (KRRO) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

KPRX currently trades at $2.68 with a QOC of 5.5/10, while KRRO trades at $13.41 with a QOC of 5.1/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).